Therefore, targeting the MUC4–Gal-3 interaction is a potential therapeutic strategy to prevent pancreatic cancer metastasis by inhibiting cancer cell adhesion to endothelial cells. The gene discussed is MUC4; the disease is pancreatic neoplasm.